VERITY Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$674K Hold
5,338
0.41% 44
2026
Q1
$744K Hold
5,338
0.5% 41
2025
Q4
$655K Hold
5,338
0.41% 44
2025
Q3
$593K Hold
5,338
0.37% 46
2025
Q2
$592K Hold
5,338
0.4% 44
2025
Q1
$598K Hold
5,338
0.44% 43
2024
Q4
$493K Hold
5,338
0.36% 52
2024
Q3
$448K Hold
5,338
0.31% 56
2024
Q2
$366K Hold
5,338
0.27% 59
2024
Q1
$391K Sell
5,338
-272
-5% -$20.9K 0.3% 58
2023
Q4
$454K Sell
5,610
-163
-3% -$12.7K 0.39% 47
2023
Q3
$433K Hold
5,773
0.41% 47
2023
Q2
$445K Hold
5,773
0.4% 47
2023
Q1
$479K Hold
5,773
0.44% 45
2022
Q4
$496K Hold
5,773
0.49% 42
2022
Q3
$356K Hold
5,773
0.37% 51
2022
Q2
$357K Buy
+5,773
New +$357K 0.35% 48
2022
Q1
Sell
-2,773
Closed -$201K 64
2021
Q4
$201K Buy
+2,773
New +$191K 0.17% 66
2020
Q3
Sell
-2,773
Closed -$213K 50
2020
Q2
$213K Hold
2,773
0.23% 47
2020
Q1
$207K Sell
2,773
-427
-13% -$29.5K 0.28% 42
2019
Q4
$208K Hold
3,200
0.2% 49
2019
Q3
$203K Sell
3,200
-2,242
-41% -$147K 0.2% 50
2019
Q2
$368K Sell
5,442
-26
-0.5% -$1.71K 0.36% 40
2019
Q1
$355K Buy
5,468
+26
+0.5% +$1.73K 0.36% 38
2018
Q4
$340K Buy
+5,442
New +$380K 0.39% 37

Other funds holding GILD

VERITY Wealth Advisors's GILD Position: Q2 2026 in Review

VERITY Wealth Advisors held its Gilead Sciences (GILD) position steady in Q2 2026 at 5,338 shares worth $674K. The position accounts for 0.41% of the portfolio, ranked #44.

VERITY Wealth Advisors first reported a position in GILD in Q4 2018 and has held it in 25 quarters since. The position peaked at $744K in Q1 2026. 536 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • VERITY Wealth Advisors held 5,338 shares of Gilead Sciences worth $674K as of Q2 2026.
  • VERITY Wealth Advisors left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.41% of VERITY Wealth Advisors's portfolio in Q2 2026, its #44 holding.
  • VERITY Wealth Advisors first reported a position in Gilead Sciences in Q4 2018 and has held it in 25 quarters since.
  • VERITY Wealth Advisors's Gilead Sciences position peaked at $744K in Q1 2026.
  • 536 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on VERITY Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.